Matthew Hershenhorn

Stock Analyst at Oppenheimer

(1.93)
# 2,984
Out of 4,910 analysts
1
Total ratings
100%
Success rate
0.73%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matthew Hershenhorn

Axsome Therapeutics
Jun 3, 2025
Initiates: Outperform
Price Target: $185
Current: $104.97
Upside: +76.24%